Avsnitt Third-generation FLT3 inhibitors in clinical development MediCom Oncology Clinical Pearls Podcasts Spela Dela
Dr. Perl provides a brief summary of what is on the horizon for FLT3 inhibitors in AML. Rss Apple Podcaster →